Ryuta Yamazaki

1.4k total citations
33 papers, 1.1k citations indexed

About

Ryuta Yamazaki is a scholar working on Molecular Biology, Pharmacology and Rheumatology. According to data from OpenAlex, Ryuta Yamazaki has authored 33 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 12 papers in Pharmacology and 9 papers in Rheumatology. Recurrent topics in Ryuta Yamazaki's work include Inflammatory mediators and NSAID effects (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and NF-κB Signaling Pathways (6 papers). Ryuta Yamazaki is often cited by papers focused on Inflammatory mediators and NSAID effects (11 papers), Rheumatoid Arthritis Research and Therapies (7 papers) and NF-κB Signaling Pathways (6 papers). Ryuta Yamazaki collaborates with scholars based in Japan and United States. Ryuta Yamazaki's co-authors include Takeshi Matsuzaki, Teruo Yokokura, Shinichi Kawai, Shusuke Hashimoto, Natsuko Kusunoki, S Hashimoto, Yutaka Mizushima, Ritsuo Aiyama, Tomihisa Koshino and Renzo Okamoto and has published in prestigious journals such as FEBS Letters, Journal of Bacteriology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Ryuta Yamazaki

33 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ryuta Yamazaki Japan 18 543 280 191 173 120 33 1.1k
Jun‐Jen Liu Taiwan 23 783 1.4× 248 0.9× 89 0.5× 181 1.0× 84 0.7× 49 1.6k
Chia‐Cheng Li Taiwan 26 552 1.0× 91 0.3× 116 0.6× 124 0.7× 97 0.8× 51 1.3k
Saori Takahashi Japan 22 814 1.5× 111 0.4× 185 1.0× 114 0.7× 104 0.9× 95 1.6k
Bill E. Cham Australia 17 659 1.2× 121 0.4× 267 1.4× 148 0.9× 43 0.4× 64 1.5k
Yasuyuki Ohtake Japan 25 1.3k 2.4× 129 0.5× 241 1.3× 182 1.1× 79 0.7× 48 2.3k
Alain De France 26 874 1.6× 201 0.7× 125 0.7× 220 1.3× 172 1.4× 46 1.8k
Venil N. Sumantran India 20 755 1.4× 116 0.4× 65 0.3× 238 1.4× 168 1.4× 48 1.4k
Shih‐Lu Wu Taiwan 24 610 1.1× 240 0.9× 118 0.6× 138 0.8× 60 0.5× 39 1.5k
Steven J. Melnick United States 20 626 1.2× 122 0.4× 86 0.5× 142 0.8× 100 0.8× 52 1.6k
Juan Cabezas‐Herrera Spain 25 839 1.5× 373 1.3× 45 0.2× 169 1.0× 58 0.5× 69 1.6k

Countries citing papers authored by Ryuta Yamazaki

Since Specialization
Citations

This map shows the geographic impact of Ryuta Yamazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuta Yamazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuta Yamazaki more than expected).

Fields of papers citing papers by Ryuta Yamazaki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuta Yamazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuta Yamazaki. The network helps show where Ryuta Yamazaki may publish in the future.

Co-authorship network of co-authors of Ryuta Yamazaki

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuta Yamazaki. A scholar is included among the top collaborators of Ryuta Yamazaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuta Yamazaki. Ryuta Yamazaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sawaguchi, Yuichi, et al.. (2021). Novel Pan-Pim Kinase Inhibitors With Imidazopyridazine and Thiazolidinedione Structure Exert Potent Antitumor Activities. Frontiers in Pharmacology. 12. 672536–672536. 17 indexed citations
2.
Suzuki, Yumiko, Satoshi Ueno, Kensuke Hayashi, et al.. (2020). Discovery of a Potent Anticancer Agent PVHD303 with in Vivo Activity. ACS Medicinal Chemistry Letters. 11(6). 1287–1291. 7 indexed citations
3.
Sawaguchi, Yuichi, et al.. (2017). Rational Design of a Potent Pan-Pim Kinases Inhibitor with a Rhodanine–Benzoimidazole Structure. Anticancer Research. 37(8). 4051–4057. 15 indexed citations
4.
Ikeda, Takashi, et al.. (2011). Synthesis of phenanthroindolizidine alkaloids and evaluation of their antitumor activities and toxicities. Bioorganic & Medicinal Chemistry Letters. 21(19). 5978–5981. 16 indexed citations
5.
Izumi, Hiroto, Tetsuro Wakasugi, Shohei Shimajiri, et al.. (2010). Role of ZNF143 in tumor growth through transcriptional regulation of DNA replication and cell‐cycle‐associated genes. Cancer Science. 101(12). 2538–2545. 44 indexed citations
6.
Kusunoki, Natsuko, Ryuta Yamazaki, & Shinichi Kawai. (2008). Pro-apoptotic effect of nonsteroidal anti-inflammatory drugs on synovial fibroblasts. Modern Rheumatology. 18(6). 542–551. 6 indexed citations
7.
Tahara, E, Hidetoshi Tahara, Masamoto Kanno, et al.. (2005). G1P3, an interferon inducible gene 6-16, is expressed in gastric cancers and inhibits mitochondrial-mediated apoptosis in gastric cancer cell line TMK-1 cell. Cancer Immunology Immunotherapy. 54(8). 729–740. 85 indexed citations
8.
Kusunoki, Natsuko, Ryuta Yamazaki, Hidero Kitasato, et al.. (2004). Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. BMC Pharmacology. 4(1). 2–2. 40 indexed citations
9.
Kusunoki, Natsuko, Ryuta Yamazaki, & Shinichi Kawai. (2003). Triptolide, an active compound identified in a traditional Chinese herb, induces apoptosis of rheumatoid synovial fibroblasts. Arthritis Research. 5(Suppl 3). 146–146. 2 indexed citations
10.
Kusunoki, Natsuko, Ryuta Yamazaki, & Shinichi Kawai. (2002). Induction of apoptosis in rheumatoid synovial fibroblasts by celecoxib, but not by other selective cyclooxygenase 2 inhibitors. Arthritis & Rheumatism. 46(12). 3159–3167. 66 indexed citations
11.
Ueno, Munehisa, et al.. (2002). SN-38 Induces Cell Cycle Arrest and Apoptosis in Human Testicular Cancer. European Urology. 42(4). 390–397. 31 indexed citations
12.
Yamazaki, Ryuta, Natsuko Kusunoki, Takeshi Matsuzaki, Shusuke Hashimoto, & Shinichi Kawai. (2002). Nonsteroidal Anti-Inflammatory Drugs Induce Apoptosis in Association with Activation of Peroxisome Proliferator-Activated Receptor γ in Rheumatoid Synovial Cells. Journal of Pharmacology and Experimental Therapeutics. 302(1). 18–25. 61 indexed citations
13.
Yamazaki, Ryuta, Natsuko Kusunoki, Takeshi Matsuzaki, Shusuke Hashimoto, & Shinichi Kawai. (2002). Selective cyclooxygenase‐2 inhibitors show a differential ability to inhibit proliferation and induce apoptosis of colon adenocarcinoma cells. FEBS Letters. 531(2). 278–284. 118 indexed citations
14.
Akimoto, Hiroshi, Ryuta Yamazaki, Shusuke Hashimoto, Takashi Sato, & Akira Itô. (2000). 4′-Hydroxy aceclofenac suppresses the interleukin-1-induced production of promatrix metalloproteinases and release of sulfated-glycosaminoglycans from rabbit articular chondrocytes. European Journal of Pharmacology. 401(3). 429–436. 25 indexed citations
15.
Yamazaki, Ryuta, Shinichi Kawai, Yutaka Mizushima, et al.. (2000). A major metabolite of aceclofenac, 4′-hydroxy aceclofenac, suppresses the production of interstitial pro-collagenase/proMMP-1 and pro-stromelysin-1/proMMP-3 by human rheumatoid synovial cells. Inflammation Research. 49(3). 133–138. 22 indexed citations
16.
Yamazaki, Ryuta, et al.. (2000). Diarylheptanoids suppress expression of leukocyte adhesion molecules on human vascular endothelial cells. European Journal of Pharmacology. 404(3). 375–385. 19 indexed citations
17.
Matsuzaki, Takeshi, Ryuta Yamazaki, S Hashimoto, & Teruo Yokokura. (1998). The Effect of Oral Feeding of Lactobacillus casei Strain Shirota on Immunoglobulin E Production in Mice. Journal of Dairy Science. 81(1). 48–53. 181 indexed citations
18.
Yamazaki, Ryuta, Ritsuo Aiyama, Takeshi Matsuzaki, S Hashimoto, & Teruo Yokokura. (1998). Anti-inflammatory effect of YPE-01, a novel diarylheptanoid derivative, on dermal inflammation in mice. Inflammation Research. 47(4). 182–186. 13 indexed citations
19.
Yamazaki, Ryuta. (1997). Aceclofenac blocks prostaglandin E2 production following its intracellular conversion into cyclooxygenase inhibitors. European Journal of Pharmacology. 329(2-3). 181–187. 7 indexed citations
20.
Matsuzaki, Takeshi, Ryuta Yamazaki, Shusuke Hashimoto, & Teruo Yokokura. (1997). Antidiabetic Effects of an Oral Administration of Lactobacillus casei in a Non-Insulin-Dependent Diabetes Mellitus (NIDDM) Model using KK-Ay Mice.. Endocrine Journal. 44(3). 357–365. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jun‐Jen Liu Breakdown of academic impact, for papers by Chia‐Cheng Li Breakdown of academic impact, for papers by Saori Takahashi Breakdown of academic impact, for papers by Bill E. Cham Breakdown of academic impact, for papers by Yasuyuki Ohtake Breakdown of academic impact, for papers by Alain De Breakdown of academic impact, for papers by Venil N. Sumantran Breakdown of academic impact, for papers by Shih‐Lu Wu Breakdown of academic impact, for papers by Steven J. Melnick Breakdown of academic impact, for papers by Juan Cabezas‐Herrera
Rankless by CCL
2026